NeuroPace Inc

Research NeuroPace Inc (NPCE) on Bullrun: market cap USD 563.57M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNPCE
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Market capUSD 563.57M
• Financial periodFY2025
• RevenueUSD 99.99M
• Revenue growth25.1%
• Net income-USD 21.47M
• Free cash flow-USD 11.34M
• Gross margin77.2%

Valuation Snapshot

latest market cap is USD 563.57M.

About NeuroPace Inc

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories.

Frequently asked questions

What is NeuroPace Inc's market cap?

NeuroPace Inc's market capitalization is USD 563.57M.

What does NeuroPace Inc do?

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy.